LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $1.12 billion. The enterprise value is $914.16 million.
Important Dates
The last earnings date was Wednesday, July 30, 2025, before market open.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
LENZ has 28.52 million shares outstanding. The number of shares has increased by 222.30% in one year.
Current Share Class | 28.52M |
Shares Outstanding | 28.52M |
Shares Change (YoY) | +222.30% |
Shares Change (QoQ) | +2.01% |
Owned by Insiders (%) | 2.73% |
Owned by Institutions (%) | 46.18% |
Float | 13.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 217.28 |
Forward PS | 40.58 |
PB Ratio | 5.44 |
P/TBV Ratio | 5.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 182.83 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.54, with a Debt / Equity ratio of 0.01.
Current Ratio | 20.54 |
Quick Ratio | 20.27 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.25% and return on invested capital (ROIC) is -19.26%.
Return on Equity (ROE) | -26.25% |
Return on Assets (ROA) | -18.44% |
Return on Invested Capital (ROIC) | -19.26% |
Return on Capital Employed (ROCE) | -29.94% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, LENZ has paid $501,000 in taxes.
Income Tax | 501,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.80% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +69.80% |
50-Day Moving Average | 31.72 |
200-Day Moving Average | 28.55 |
Relative Strength Index (RSI) | 67.77 |
Average Volume (20 Days) | 580,605 |
Short Selling Information
The latest short interest is 3.82 million, so 13.40% of the outstanding shares have been sold short.
Short Interest | 3.82M |
Short Previous Month | 3.85M |
Short % of Shares Out | 13.40% |
Short % of Float | 29.16% |
Short Ratio (days to cover) | 14.15 |
Income Statement
In the last 12 months, LENZ had revenue of $5.00 million and -$52.40 million in losses. Loss per share was -$1.90.
Revenue | 5.00M |
Gross Profit | 5.00M |
Operating Income | -61.96M |
Pretax Income | -117.37M |
Net Income | -52.40M |
EBITDA | -61.87M |
EBIT | -61.96M |
Loss Per Share | -$1.90 |
Full Income Statement Balance Sheet
The company has $209.52 million in cash and $1.05 million in debt, giving a net cash position of $208.47 million or $7.31 per share.
Cash & Cash Equivalents | 209.52M |
Total Debt | 1.05M |
Net Cash | 208.47M |
Net Cash Per Share | $7.31 |
Equity (Book Value) | 206.37M |
Book Value Per Share | 7.24 |
Working Capital | 203.20M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$47.22 million and capital expenditures -$685,000, giving a free cash flow of -$47.90 million.
Operating Cash Flow | -47.22M |
Capital Expenditures | -685,000 |
Free Cash Flow | -47.90M |
FCF Per Share | -$1.68 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,239.16% |
Pretax Margin | -1,037.94% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -222.30% |
Shareholder Yield | -222.30% |
Earnings Yield | -4.67% |
FCF Yield | -4.27% |
Dividend Details Analyst Forecast
The average price target for LENZ is $47.00, which is 19.41% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $47.00 |
Price Target Difference | 19.41% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LENZ has an Altman Z-Score of 38.28 and a Piotroski F-Score of 1.
Altman Z-Score | 38.28 |
Piotroski F-Score | 1 |